- Home
- MNKD vs MMI Comparison
MNKD vs MMI Comparison
Compare MNKD & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- MMI
- Stock Information
- Founded
- MNKD 1991
- MMI 1971
- Country
- MNKD United States
- MMI United States
- Employees
- MNKD N/A
- MMI N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- MMI Real Estate
- Sector
- MNKD Health Care
- MMI Finance
- Exchange
- MNKD Nasdaq
- MMI Nasdaq
- Market Cap
- MNKD 1.2B
- MMI 1.2B
- IPO Year
- MNKD 2004
- MMI 2013
- Fundamental
- Price
- MNKD $3.73
- MMI $30.77
- Analyst Decision
- MNKD Buy
- MMI Sell
- Analyst Count
- MNKD 6
- MMI 2
- Target Price
- MNKD $9.17
- MMI $30.00
- AVG Volume (30 Days)
- MNKD 3.1M
- MMI 114.4K
- Earning Date
- MNKD 08-06-2025
- MMI 08-07-2025
- Dividend Yield
- MNKD N/A
- MMI 1.62%
- EPS Growth
- MNKD 149.32
- MMI N/A
- EPS
- MNKD 0.11
- MMI N/A
- Revenue
- MNKD $301,736,000.00
- MMI $725,903,000.00
- Revenue This Year
- MNKD $13.62
- MMI $12.22
- Revenue Next Year
- MNKD $15.18
- MMI $23.33
- P/E Ratio
- MNKD $34.33
- MMI N/A
- Revenue Growth
- MNKD 21.48
- MMI 17.89
- 52 Week Low
- MNKD $3.38
- MMI $27.61
- 52 Week High
- MNKD $7.63
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- MNKD 48.69
- MMI 49.58
- Support Level
- MNKD $3.60
- MMI $28.66
- Resistance Level
- MNKD $3.81
- MMI $31.34
- Average True Range (ATR)
- MNKD 0.17
- MMI 1.19
- MACD
- MNKD -0.00
- MMI -0.04
- Stochastic Oscillator
- MNKD 50.72
- MMI 58.33
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.